U.S. flag

An official website of the United States government

GTR Home > Tests > High-Resolution Rapid Microarray (CGH and SNP)

Laboratory contact

Laboratory information


Allele Diagnostics, ADx
Allele Diagnostics

Laboratory director(s)

  • Blake Atwood, PhD, ABMG, FACMG, DABMG, Lab Director
  • Beth Torchia, PhD, ABMG, FACMG, DABMG, Lab Director
  • Ferrin Wheeler, PhD, ABMG, FACMG, DABMG, Lab Director

Laboratory contact for this test

  • Annie Morton, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
  • Phone Number: 844-255-3532
  • Email: info@allelediagnostics.com
  • Fax Number: 509-232-5779

Laboratory contact

  • 120 N. Pine St., Suite 152
  • WA
  • Spokane, Washington 99202
  • United States

Laboratory credentials

CLIA certification

  • Number: 50D2086351, Expiration: 2023-06-30

State license(s)

  • CA - California Department of Public Health CDPH, License number: CDS 00800591, Expiration: 2023-05-03
  • WA - Washington State Department of Health DOH, License number: 50D2086351, Expiration: 2023-06-30
  • PA - Pennsylvania Department of Health PADOH, License number: 034407, Expiration: 2023-08-15


  • CAP, Number: 9018482, Expiration: 2023-04-21

Practice guidelines

  • ACMG, 2021
    Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)
  • NSGC, 2021
    National Society of Genetic Counselors Position Statement: Prenatal Cell-Free DNA Screening
  • ACMG, 2016
    Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics
  • ESHG/ASHG, 2015
    Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.
  • NSGC, 2013
    Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. (Replaced by NSCG, 2021 Statement)
  • ACMG, 2013
    ACMG statement on noninvasive prenatal screening for fetal aneuploidy. (See 2016 Update)
  • ICFMM, 2013
    Position Statement from the Italian College of Fetal Maternal Medicine: Non-invasive prenatal testing (NIPT) by maternal plasma DNA sequencing.
  • NSGC, 2013
    NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy.

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.